A Study of Language Interpretation Solutions for People With Breast Cancer
Recruiting
N/A
Interventional Study
Breast Cancer
Breast Cancer Stage II
Breast Cancer Stage III
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 700 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study will be conducted in 2 overlapping phases. In Phase 1, there will be a 3-arm randomized controlled trial of Remote Simultaneous Medical Interpreting/RSMI (Arm 1), versus Remote Consecutive Medical Interpreting/RCMI (Arm 2) and versus Remote Consecutive Video Medical Interpreting/RCVI (Arm 3) in breast cancer outpatient clinical encounters with Spanish- and Mandarin-speaking patients with…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Phase I Patients
* Age \>=18 years (per EMR)
* Preferred language for healthcare is Spanish or Mandarin (per self-report)
* Limited English Proficient; cannot speak English "very well" (per self-report)
* Diagnosis of breast cancer or gastrointestinal (per EMR)
* Will be visiti…
Contacts